On June 30, 2017, Connecticut Governor Malloy signed the House Bill 7052, An Act Preventing Prescription Opioid Diversion and Abuse, which went into effect on January 1, 2018. The bill was unanimously signed to take action against drug abuse in a state where on average, two people die each day because of a drug overdose.
CPMRS - Connecticut Prescription Monitoring & Reporting System. Collects prescription information for Schedule II - Schedule V substances in Connecticut. Visit CPMRS Site to help answer your FAQs or registering for the CT mandate.
Schedule II-V Substances - Controlled substances that are for medical use, but have the potential for abuse, safety or dependence liability. Ex: codeine, oxycodone, benzphetamine, barbital